Valentino D’Onofrio

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 84 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

Organ-specific genome diversity of replication-competent SARS-CoV-2

Jolien Van Cleemput, Willem van Snippenberg, Laurens Lambrechts et al. · Nature Communications · 2021 · 76 citations · Full text

Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia

Valentino D’Onofrio, Rick Conzemius, Dijana Varda-Brkić et al. · Infection Genetics and Evolution · 2020 · 55 citations · Full text

Antimicrobial Susceptibility, Health Sciences, Antibiotics +9

An observational study of innate immune responses in patients with acute appendicitis

Toon Peeters, Sandrina Martens, Valentino D’Onofrio et al. · Scientific Reports · 2020 · 28 citations · Full text

A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis

Valentino D’Onofrio, Dries Heylen, Murih Pusparum et al. · Journal of Intensive Care · 2022 · 22 citations · Full text